Published in Oncol Rep on April 29, 2013
Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma. PLoS One (2015) 1.45
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis. J Exp Clin Cancer Res (2013) 0.79
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers. BMC Med Genet (2015) 0.77
MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjects. Int J Clin Exp Med (2015) 0.76
Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis. Med Sci Monit (2016) 0.75
TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women. Med Oncol (2014) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Surfing the p53 network. Nature (2000) 35.36
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett (1997) 11.19
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat Med (2004) 5.48
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res (2006) 3.26
Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell (2000) 2.30
The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control (2009) 1.96
MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: evidence from 21 case-control studies. Cancer Epidemiol Biomarkers Prev (2007) 1.52
Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol (2005) 1.49
A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells. J Biol Chem (2005) 1.47
Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res (1992) 1.47
The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res (1993) 1.45
MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis (2007) 1.35
Endometrial carcinoma: pathology and genetics. Pathology (2007) 1.32
Cell cycle regulatory functions of the human oncoprotein MDM2. Mol Cancer Res (2003) 1.28
Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res (1993) 1.11
No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer. Cancer Lett (2005) 1.04
Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. Gynecol Oncol (2006) 1.04
MDM2 SNP309 is associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 0.98
MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. BMC Cancer (2011) 0.97
Mdm2 in growth signaling and cancer. Growth Factors (2005) 0.97
MDM2 SNP309 contributes to tumor susceptibility: a meta-analysis. J Genet Genomics (2011) 0.96
Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. Gynecol Oncol (2009) 0.94
Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer. Hum Cell (2009) 0.93
Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin Cancer Res (1995) 0.92
MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis. Hum Cell (2011) 0.91
MDM2SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk. Oncology (2008) 0.91
Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone (1997) 0.90
p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Gynecol Oncol (2004) 0.90
Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk. Anticancer Res (2007) 0.90
Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. Jpn J Cancer Res (2000) 0.88
No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prev (1995) 0.88
Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer. Hum Cell (2009) 0.85
An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer. Gynecol Oncol (2007) 0.85
Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway. J Biol Chem (2002) 0.85
Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett (2005) 0.84
Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett (2001) 0.84
Contribution of enhanced transcriptional activation by ER to [12Val] K-Ras mediated NIH3T3 cell transformation. Oncogene (1997) 0.81
WAF1 genotype and endometrial cancer susceptibility. Gynecol Oncol (1999) 0.78
Maternal exposure to high levels of dioxins in relation to birth weight in women affected by Yusho disease. Environ Int (2011) 3.17
Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors. Hum Pathol (2009) 2.11
Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulating cell cycle-related protein expression. Menopause (2008) 2.06
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol (2007) 1.66
Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment. Genome Res (2014) 1.64
Difference in neutrophil superoxide generation during pregnancy between preeclampsia and essential hypertension. Hypertension (2007) 1.42
Characterization of side-population cells in human normal endometrium. Hum Reprod (2007) 1.42
Reassessment of the utility of frozen sections in endometrial cancer surgery using tumor diameter as an additional factor. Am J Obstet Gynecol (2011) 1.41
Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases. Am J Surg Pathol (2008) 1.22
ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome. Nucleic Acids Res (2005) 1.21
Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer. Int J Cancer (2005) 1.15
Identification of FOXC1 as a TGF-beta1 responsive gene and its involvement in negative regulation of cell growth. Genomics (2002) 1.10
Loss of the maternal imprint in Dnmt3Lmat-/- mice leads to a differentiation defect in the extraembryonic tissue. Dev Biol (2006) 1.10
The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol Hum Reprod (2004) 1.09
Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1. Int J Cancer (2006) 1.07
Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study. Int J Gynecol Cancer (2010) 1.07
Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression. Cancer Sci (2007) 1.06
Genome-wide definitive haplotypes determined using a collection of complete hydatidiform moles. Genome Res (2005) 1.04
Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation. Clin Cancer Res (2008) 1.02
Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens (2008) 1.00
The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecol Oncol (2013) 1.00
FGF4-dependent stem cells derived from rat blastocysts differentiate along the trophoblast lineage. Dev Biol (2011) 1.00
Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol (2010) 1.00
Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am J Pathol (2009) 0.97
Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice. Biochem Biophys Res Commun (2008) 0.95
Prenatal diagnosis of a retroperitoneal lymphangioma: a case and review. Fetal Diagn Ther (2008) 0.95
Associations between anxiety, depression and insomnia in peri- and post-menopausal women. Maturitas (2012) 0.94
The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci (2008) 0.92
SATB homeobox proteins regulate trophoblast stem cell renewal and differentiation. J Biol Chem (2011) 0.92
Reversible posterior encephalopathy syndrome followed by MR angiography-documented cerebral vasospasm in preeclampsia-eclampsia: report of 2 cases. Cerebrovasc Dis (2008) 0.92
Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-alpha, and placental apoptosis. Am J Hypertens (2008) 0.92
Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem (2008) 0.91
K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival. Cancer Res (2004) 0.91
Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis. Ann Thorac Surg (2004) 0.90
Identification and characterization of two forms of mouse MUTYH proteins encoded by alternatively spliced transcripts. Nucleic Acids Res (2004) 0.90
Clinical manifestations of pregnancy in patients with Takayasu arteritis: experience from a single tertiary center. Arch Gynecol Obstet (2011) 0.90
Evaluation of haplotype inference using definitive haplotype data obtained from complete hydatidiform moles, and its significance for the analyses of positively selected regions. PLoS Genet (2009) 0.89
CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls. Gynecol Oncol (2007) 0.89
Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line. PLoS One (2011) 0.89
Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Int J Cancer (2009) 0.89
NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif. Genomics (2003) 0.89
Oxidative DNA damage in XPC-knockout and its wild mice treated with equine estrogen. Chem Res Toxicol (2008) 0.89
Spontaneous post-partum rupture of an ovarian artery aneurysm: a case report of successful embolization and a review of the published work. J Obstet Gynaecol Res (2014) 0.89
Improvement in the outcome of patients with antenatally diagnosed congenital diaphragmatic hernia using gentle ventilation and circulatory stabilization. Pediatr Surg Int (2009) 0.88
Long-term effects of polychlorinated biphenyls and dioxins on pregnancy outcomes in women affected by the Yusho incident. Environ Health Perspect (2008) 0.88
Expression of beta-tubulin isotypes in human primary ovarian carcinoma. Gynecol Oncol (2007) 0.88
Level of reactive oxygen species induced by p21Waf1/CIP1 is critical for the determination of cell fate. Cancer Sci (2009) 0.88
Associations among depression, anxiety and somatic symptoms in peri- and postmenopausal women. J Obstet Gynaecol Res (2013) 0.88
Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2. J Reprod Med (2005) 0.87
Oxidative stress produced by xanthine oxidase induces apoptosis in human extravillous trophoblast cells. J Reprod Dev (2012) 0.87
Intrapartum placement of an inferior vena cava filter for a woman with hereditary antithrombin III deficiency: its role in the prevention of fatal pulmonary embolism. J Obstet Gynaecol Res (2008) 0.87
Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas. Mod Pathol (2009) 0.86
The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice. Genomics (2006) 0.86
Transplacental digitalization for nonimmune hydrops fetalis caused by isolated noncompaction of the ventricular myocardium. J Ultrasound Med (2007) 0.86
Increased inflammatory markers are associated with early periventricular leukomalacia. Dev Med Child Neurol (2007) 0.86
Uterine artery embolization along with the administration of methotrexate for cervical ectopic pregnancy: technical and clinical outcomes. AJR Am J Roentgenol (2009) 0.86
Complete mole coexistent with a twin fetus. J Obstet Gynaecol Res (2006) 0.86
Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway. J Biol Chem (2002) 0.85
Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding. Exp Cell Res (2010) 0.85
Successful management of cervico-isthmic pregnancy delivered at term. J Obstet Gynaecol Res (2012) 0.85
The maternally expressed gene Tssc3 regulates the expression of MASH2 transcription factor in mouse trophoblast stem cells through the AKT-Sp1 signaling pathway. J Biol Chem (2012) 0.85
Prenatal sonographic diagnosis of a hiatal hernia in a fetus with asplenia syndrome. J Ultrasound Med (2007) 0.85
An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer. Gynecol Oncol (2007) 0.85
The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer. Int J Gynecol Cancer (2009) 0.84
Ischemic ileal perforation in the donor of monochorionic twins complicated by twin-twin transfusion syndrome. Fetal Diagn Ther (2009) 0.84
Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway. Mol Cell Endocrinol (2003) 0.84
Retroperitoneal schwannoma bearing at the right vaginal wall. J Obstet Gynaecol Res (2004) 0.84
Effects of S-equol and natural S-equol supplement (SE5-OH) on the growth of MCF-7 in vitro and as tumors implanted into ovariectomized athymic mice. Food Chem Toxicol (2011) 0.84
Cervical length predicts placental adherence and massive hemorrhage in placenta previa. J Obstet Gynaecol Res (2011) 0.83
A retrospective chart review of the perinatal period in 22 pregnancies of 16 women with Moyamoya disease. J Clin Neurosci (2012) 0.83
A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol Oncol (2003) 0.83
Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response. Mol Cancer Ther (2011) 0.83
Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances. Arch Gynecol Obstet (2010) 0.83
HOP/NECC1, a novel regulator of mouse trophoblast differentiation. J Biol Chem (2007) 0.83
Involvement of puromycin-sensitive aminopeptidase in proteolysis of tau protein in cultured cells, and attenuated proteolysis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) mutant tau. Psychogeriatrics (2009) 0.83
Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma. Gynecol Oncol (2004) 0.83